Diagnostic criteria for dyslipidemia: Executive summary of the japan atherosclerosis society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in japan - 2012 version

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 8, 2013, Pages 655-660

  Teramoto, Tamio ^a   Sasaki, Jun ^a   Ishibashi, Shun ^a   Birou, Sadatoshi ^a   Daida, Hiroyuki ^a   Dohi, Seitaro ^a   Egusa, Genshi ^a   Hiro, Takafumi ^a   Hirobe, Kazuhiko ^a   Iida, Mami ^a   Kihara, Shinji ^a   Kinoshita, Makoto ^a   Maruyama, Chizuko ^a   Ohta, Takao ^a   Okamura, Tomonori ^a   Yamashita, Shizuya ^a   Yokode, Masayuki ^a   Yokote, Koutaro ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; HYPOCHOLESTEROLEMIA; JAPAN; LIFESTYLE MODIFICATION; LIPID ANALYSIS; MORTALITY; PRACTICE GUIDELINE; RISK FACTOR;

ATHEROSCLEROSIS; DYSLIPIDEMIAS; HUMANS; JAPAN;

EID: 84883274930     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.17152     Document Type: Article

References (55)

1. Imano H, Noda H, Kitamura A, Sato S, Kiyama M, Sankai T, Ohira T, Nakamura M, Yamagishi K, Ikeda A, Shimamoto T, Iso H: Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: the Circulatory Risk in Communities Study (CIRCS). Prev Med, 2011; 52: 381-386
2. Okamura T, Tanaka H, Miyamatsu N, Hayakawa T, Kadowaki T, Kita Y, Nakamura Y, Okayama A, Ueshima H; NIPPON DATA80 Research Group: The relationship between serum total cholesterol and all-cause or causespecific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis, 2007; 190: 216-223
3. Okamura T, Kadowaki T, Hayakawa T, Kita Y, Okayama A, Ueshima H; for the NIPPON DATA80 research group: What cause of mortality can we predict by cholesterol screening in the Japanese general population? Int J Med, 2003; 253:169-180
4. Hirobe K, Fujioka S, Goto K, Terai T, Dohi S: The incidence of workplace myocardial infarction, focusing on serum lipid results: a 3M Study. The Journal of Adult Diseases, 2003; 33: 1335-1339 (in Japanese)
5. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation, 1998; 97: 1837-1847
6. Konishi M, Iida M, Naito Y, Terao A, Kiyama M, Kojima S, Doi M, Shimamoto T, Komachi Y: Studies on the relationship between the trend of serum total cholesterol level and the incidence of cerebro-cardio-vascular diseases based on the follow-up studies in Akita and Osaka. With a special reference to the optimal serum total cholesterol level. Journal of Atherosclerosis and Thrombosis, 1987; 15: 1115-1123 (in Japanese)
7. Kodama K, Sasaki H, Shimizu Y: Trend of coronary heart disease and its relationship to risk factors in a Japanese population: a 26-year follow-up, Hiroshima/Nagasaki study. Circ J, 1990; 54: 414-421
8. Kitamura A, Noda H, Nakamura M, Kiyama M, Okada T, Imano H, Ohira T, Sato S, Yamagishi K, Iso H: Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: the Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb, 2011; 18: 454-463
9. Iso H, Naito Y, Sato S, Kitamura A, Okamura T, Sankai T, Shimamoto T, Iida M, Komachi Y: Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol, 2001; 153: 490-499
10. Kukita H, Hiwada K: Hypertriglyceridemia as a risk factor for coronary artery disease. Ther Res, 1993; 14:551-558
11. Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folsom AR, Sato S, Kiyama M, Nakamura M, Sankai T, Shimamoto T, Komachi Y: High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation, 1994; 89: 2533-2539
12. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intevention Trial: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia: primary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J, 2002; 66: 1087-1095
13. Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H: J-LIT Study Group. Japan Lipid Intevention Trial: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J, 2002; 66: 1096-1100
14. Saito I, Folsom AR, Aono H, Ozawa H, Ikebe T, Yamashita T: Comparison of fatal coronary heart disease occurrence based on population surveys in Japan and the USA. Int J Epidemiol, 2000; 29: 837-844
15. Menotti A, Blackburn H, Kromhout D, Nissinen A, Fidanza F, Giampaoli S, Buzina R, Mohacek I, Nedeljkovic S, Aravanis C, Toshima H: Changesin population cholesterol levels and coronary heart disease deaths in seven countries. Eur Heart J, 1997; 18: 566-571
16. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Nedelijković S, Nissinen A, Toshima H: Serum total cholesterol and long-term coronary heart disease mortality in different cultures: twenty five-year follow-up of the seven countries study. JAMA, 1995; 274: 131-136
17. Hirobe K, Terai T, Fujioka S, Goto K, Dohi S; 3M-Study Project Committee of the Japan Association of Occupational Physicians "San-yu-kai": Morbidity of Myocardial Infarction Multicenter Study in Japan (3M Study): study design and event rates for myocardial infarction and coronary death by age category in Japanese workers. Circ J, 2005; 69: 767-773
18. Ministry of Health, Labour and Welfare: The 3rd, 4th, and 5th circulatory disease basic research. 1980, 1990, 2000
19. Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T, Ohira T, Tanigawa T, Yamagishi K, Nakamura M, Konishi M, Shimamoto T, Iida M, Komachi Y: Trends in the Incidence of Coronary Heart Disease and Stroke and Their Risk Factors in Japan, 1964 to 2003 The Akita-Osaka Study. JACC, 2008; 52: 71-79
20. Takii T, Yasuda S, Takahashi J, Ito K, Shiba N, Shirato K, Shimokawa H; MIYAGI-AMI Study Investigators: Trends in acute myocardial infarction incidence and mortality over 30 years in Japan: report from the MIYAGI-AMI Registry Study. Circ J, 2010; 74: 93-100
21. Miller WG, Myers GL, Sakurabayashi I, Bachmann LM, Caudill SP, Dziekonski A, Edwards S, Kimberly MM, Korzun WJ, Leary ET, Nakajima K, Nakamura M, Nilsson G, Shamburek RD, Vetrovec GW, Warnick GR, Remaley AT; Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures: Clin Chem, 2010; 56: 977-986
22. Nakamura M, Koyama I, Iso H, Sato S, Okazaki M, Kiyama M, Shimamoto T, Konishi M: Measurement performance of reagent manufacturers by Centers for Disease Control and Prevention/Cholesterol Reference Method Laboratory Network lipid standardization specified for metabolic syndrome focused health checkups program in Japan. J Atheroscler Thromb, 2009; 16: 756-763
23. Nakamura M, Koyama I, Iso H, Sato S, Okazaki M, Kayamori Y, Kiyama M, Kitamura A, Shimamoto T, Ishikawa Y, et al: Ten-year evaluation of homogeneous low-density lipoprotein cholesterol methods developed by Japanese manufacturers. Application of the Centers for Disease Control and Prevention/Cholesterol Reference Method Laboratory Network lipid standardization protocol. J Atheroscler Thromb, 2010; 17: 1275-1281
24. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Miyamoto Y, Yoshimasa Y, Okayama A: Low density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis, 2009; 203: 587-592
25. Tanabe N, Iso H, Okada K, Nakamura Y, Harada A, Ohashi Y, Ando T, Ueshima H; Japan Arteriosclerosis Longitudinal Study Group: Serum total and non highdensity lipoprotein cholesterol and the risk prediction of cardiovascular events-the JALS-ECC-. Circ J, 2010; 74: 1346-1356
26. Tarui S (section leader): Specific diseases, Ministry of Health and Welfare. Research Committee of primary hyperlipidemia. Study report in 1986. 1987
27. Wakugami K, Iseki K, Kimura Y, Okumura K, Ikemiya Y, Muratani H, Fukiyama K: Relationship between serum cholesterol and the risk of acute myocardial infarction in a screened cohort in Okinawa, Japan. Circ J, 1998; 62: 7-14
28. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y; for the MEGA Study Group: Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomized controlled trial. Lancet, 2006; 368: 1155-1163
29. The Kyushu Lipid Intervention Study Group: Pravastatin use and risk of coronary events and cerebral infarction in Japanese men with moderate hypercholesterolemia: The Kyushu Lipid Intervention Study (KLIS). J Atheroscler Thoromb, 2000; 7: 110-121
30. Ito H, Ouchi Y, Ohashi Y, Saito Y, Ishikawa T, Nakamura H, Orimo H: A comparison of low versus standard dose pravastatin therapy for the prevention of cardiovascular events in the elderly: the pravastatin anti-atherosclerosis trial in the elderly (PATE). J Atheroscler Thromb, 2001; 8: 33-44
31. Chikamori T, Sugimoto K, Hamada T, Kitaoka H, Furuno T, Seo H, Doi Y: Efficacy of cholesterol lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitor. J Cardiol, 2000; 35: 95-101
32. Carleton RA, Dwyer J, Finberg L, Flora J, Goodman DS, Grundy SM, Havas S, Hunter GT, Kritchevsky D, Lauer RM: Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. A statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Circulation, 1991; 83: 2154-2232
33. No authors listed: National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation, 1994; 89: 1333-1445
34. Oikawa S, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, Saito Y, Sasaki J, Shimamoto K, Itakura H: Risk of coronary events in Japanese patients with both hypercholesterolemia and type 2 diabetes mellitus on lowdose simvastatin therapy: Implication from Japan Lipid Intervention Trial (J-LIT). Atherosclerosis, 2007; 191: 440-446
35. Yokokawa H, Yasumura S, Tanno K, Ohsawa M, Onoda T, Itai K, Sakata K, Kawamura K, Tanaka F, Yoshida Y, Nakamura M, Terayama Y, Ogawa A, Okayama A: Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural population. J Atheroscler Thromb, 2011; 18: 89-98
36. Okamura T, Hayakawa T, Kadowaki T, Kita Y, Okayama A, Ueshima H; NIPPON DATA90 Research Group: The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-yearfollow-up study in the Japanese general population. Atherosclerosis, 2006; 184: 143-150
37. Satoh H, Nishino T, Tomita K, Saijo Y, Kishi R, Tsutsui H: Risk factors and the incidence of coronary artery disease in young middle-aged Japanese men: results from a 10-yearcohort study. Intern Med, 2006; 45: 235-239
38. Maruyama K, Hirobe K, Noda H, Iso H, Dohi S, Terai T, Fujioka S, Goto K, Horie S, Nakano S: Associations between blood lipid profiles and risk of myocardial infarction among Japanese male workers: 3M Study. J Atheroscler Thromb, 2009; 16: 714-721
39. Noda H, Iso H, Saito I, Konishi M, Inoue M, Tsugane S; JPHC Study Group: The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center based study. Hypertens Res, 2009; 32: 289-290
40. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Kita T: Serum lipid survey and its recent trend in the general Japanese population in 2000. J Atheroscler Thromb, 2005; 12: 98-106
41. Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, Woodward M; AsiaPacific Cohort Studies Collaboration: Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation, 2004; 110: 2678-2686
42. Satoh H, Nishino T, Tomita K, Tsutsui H: Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men. Circ J, 2006; 70: 227-231
43. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Ono Y, Nishimura K, Okayama A, Miyamoto Y: A revised definition of the metabolic syndrome predicts coronary artery disease and ischemic stroke after adjusting for low density lipoprotein cholesterol in a 13-year cohort study of Japanese: the Suita study. Atherosclerosis, 2011; 217: 201-206
44. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V: Triglycerides and the risk of coronary heart disease: 10, 158 incident cases among 262, 525 participants in 29 Western prospective studies. Circulation, 2007; 115: 450-458
45. Castelli WP: Lipids, risk factors and ischemic heart disease. Atherosclerosis, 1996; 124 (Suppl): S1-S9
46. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM: Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA, 2007; 298: 309-316
47. Labreuche J, Touboul PJ, Amarenco P: Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies. Atherosclerosis, 2009; 203: 331-345
48. Antonios N, Angiolillo DJ, Silliman S: Hypertriglyceridemia and ischemic stroke. Eur Neurol, 2008; 60: 269-278
49. Okamura T, Kokubo Y, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, Yoshimasa Y, Okayama A: Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: the Suita study. Atherosclerosis, 2010; 209: 290-294
50. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL: Non-high density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med, 2001; 161: 1413-1419
51. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB: Non-high density lipoprotein cholesterol and apolipoprotein Bin the prediction of coronary heart disease in men. Circulation, 2005; 112: 3375-3383
52. Noda H, Iso H, Irie F, Sairenchi T, Ohtaka E, Ohta H: Association between non high-density lipoprotein cholesterol concentration sand mortality from coronary heart disease among Japanese men and women: the Ibaraki Prefectural Health Study. J Atheroscler Thromb, 2010; 17: 30-36
53. Sasaki J, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Itakura H, Hishida H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K, Matsuzawa Y; JELIS Investigators: Relationship between Coronary Artery Disease and Non HDL-C, and Effect of Highly Purified EPA on the Risk of Coronary Artery Disease in Hypercholesterolemic Patients Treated with Statins: Sub-Analysis of the Japan EPA Lipid Intervention Study (JELIS). J Atheroscler Thromb, 2012; 19: 194-204
54. Shimano H, Arai H, Harada-Shiba M, Ueshima H, Ohta T, Yamashita S, Gotoda T, Kiyohara Y, Hayashi T, Kobayashi J, Shimamoto K, Bujo H, Ishibashi S, Shirai K, Oikawa S, Saito Y, Yamada N: Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second target. J Atheroscler Thromb, 2008; 15: 116-121
55. Sugimoto K, Isobe K, Kawakami Y, Yamada N: The relationship between non-HDL cholesterol and other lipid parameters in Japanese subjects. J Atheroscler Thromb, 2005; 12: 107-110